Qlaris Bio
PrivateLast Round
Seed Round
Jun 17, 2026
Total Funding Raised
$49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Qlaris Bio is a biotechnology company that develops innovative, first-in-class therapies for serious and debilitating ophthalmic diseases, with a primary focus on glaucoma and ocular hypertension.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qlaris Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Qlaris Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 17, 2026 | ||||
| Series B | Apr 30, 2024 | ||||
| Series A | Aug 1, 2019 |
Key People
Founding team and executive leadership
Qlaris Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Leaf Venture Partners | Series B, Series A |
| abrdn Inc. | Series B |
| Mayo Clinic Ventures | Series B |
| Canaan Partners | Series B, Series A |
| Aberdeen | Series B |
| Mayo Clinic Ventures | Series B |
| Correlation Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Raised $4M in a Seed Round.
- Mar 1, 2026
Fred Guerard appointed as new President and CEO.
Qlaris Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Qlaris Bio's valuation, stock price, and market status.